
- April 2024
- Volume 20
- Issue 4
- Pages: 6
Element Launches New Pharmaceutical Testing Service
Element Materials Technology introduced its Rapid Response Pharmaceutical Testing Service, providing expedited testing and focusing on various requirements including active ingredients and final drug products, extractables and leachables, degradation production, and elemental impurities.
Element Materials Technology introduced its Rapid Response Pharmaceutical Testing Service, providing expedited testing and focusing on various requirements including active ingredients and final drug products, extractables and leachables, degradation production, and elemental impurities.
A case study done by the service using headspace gas chromatography mass spectrometry (HS-GC–MS) identified a volatile organic substance, cyclohexanone (1).
“We understand the critical importance of timely and precise testing in the pharmaceutical industry, and our new service is designed to address these needs head-on,” Iain Gibb, general manager of Element’s Manchester, UK lab, said in a press release.
Reference
(1) Ludlow, M. Characterization of Adhesive Related Leachable Deriving from Medical Infusion Bag. Element. Element Materials Technology, 2024.
Articles in this issue
almost 2 years ago
Monitoring PFAS in Aquatic Environmentsalmost 2 years ago
Rising Stars of Separation Science: David Steineralmost 2 years ago
The 26th Norwegian Symposium on Chromatographyalmost 2 years ago
EuSP2024 and GSAC2024 Previewalmost 2 years ago
GC–TOF-MS Finds >250 Volatile Compounds in E-Cigarette Liquidsalmost 2 years ago
GC–MS Analysis of PFAS Expands Knowledge of Toxicokinetic DataNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.




